Analysts Offer Insights on Healthcare Companies: REPRO-MED Systems (KRMD), Lumos Pharma (LUMO) and Curaleaf Holdings (OtherCURLF)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on REPRO-MED Systems (KRMD – Research Report), Lumos Pharma (LUMO – Research Report) and Curaleaf Holdings (CURLF – Research Report).

REPRO-MED Systems (KRMD)

In a report released today, Alexander Nowak from Craig-Hallum maintained a Buy rating on REPRO-MED Systems, with a price target of $23.00. The company’s shares closed last Wednesday at $2.37, close to its 52-week low of $2.13.

According to TipRanks.com, Nowak is a 2-star analyst with an average return of 0.0% and a 40.4% success rate. Nowak covers the Healthcare sector, focusing on stocks such as NeuroOne Medical Technologies, Streamline Health Solutions, and InfuSystem Holdings, Inc.

Currently, the analyst consensus on REPRO-MED Systems is a Moderate Buy with an average price target of $13.00, representing a 439.4% upside. In a report issued on August 3, Piper Sandler also maintained a Buy rating on the stock with a $3.00 price target.

See Insiders’ Hot Stocks on TipRanks >>

Lumos Pharma (LUMO)

Piper Sandler analyst Yasmeen Rahimi maintained a Buy rating on Lumos Pharma today and set a price target of $26.00. The company’s shares closed last Wednesday at $3.00, close to its 52-week low of $2.95.

According to TipRanks.com, Rahimi is a 4-star analyst with an average return of 6.6% and a 36.0% success rate. Rahimi covers the Healthcare sector, focusing on stocks such as Structure Therapeutics, Inc. Sponsored ADR, Sagimet Biosciences, Inc. Class A, and Crinetics Pharmaceuticals.

Currently, the analyst consensus on Lumos Pharma is a Moderate Buy with an average price target of $27.00, representing a 746.4% upside. In a report released today, H.C. Wainwright also reiterated a Buy rating on the stock with a $28.00 price target.

Curaleaf Holdings (CURLF)

Craig-Hallum analyst Eric Des Lauriers maintained a Hold rating on Curaleaf Holdings today and set a price target of $275.00. The company’s shares closed last Wednesday at $3.05, close to its 52-week low of $2.19.

According to TipRanks.com, Lauriers is a 3-star analyst with an average return of 4.6% and a 37.5% success rate. Lauriers covers the NA sector, focusing on stocks such as Goodness Growth Holdings, Green Thumb Industries, and Purple Innovation.

Currently, the analyst consensus on Curaleaf Holdings is a Moderate Buy with an average price target of $40.06.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.